Diadexus, Inc. (OTCPK:DDXS) announced that it has entered into a securities purchase agreement for private placement of up to 261,780 common shares at a price of $3.82 per share for gross proceeds of $1,000,000 on September 4, 2015. The transaction included participation from new investor OriGene Technologies, Inc. The company has issued securities pursuant to exemption provided under Regulation D.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2021 | Diadexus, Inc. Went Out of Business | CI |
2018 | Motion for Asset Sale Approved for Diadexus, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 410 | |
-28.10% | 1.35B | |
-19.52% | 56.65M |
- Stock Market
- Equities
- DDXSQ Stock
- News Diadexus, Inc.
- Diadexus, Inc. announced that it has received $1 million in funding from OriGene Technologies, Inc..